AstraZeneca bets $247m AI can create a cancer-fighting antibody 2023-12-05[theregister.co.uk] Startup Absci will turn to its generative AI algorithms to design synthetic protein
Pharma giant AstraZeneca has signed a $247 million deal with Ai drug creation company Absci to develop an antibody designed to fight cancer. Részletek >